Hikma Pharmaceuticals PLC (LON: HIK)

Hikma Pharmaceuticals Revenue

Hikma Pharmaceuticals had revenue of $1.57B USD in the half year ending June 30, 2024, with 29.35% growth. This brings the company's revenue in the last twelve months to $3.02B, up 10.47% year-over-year. In the year 2023, Hikma Pharmaceuticals had annual revenue of $2.88B with 14.22% growth.

• Revenue (ttm): $3.02B
• Revenue Growth: +10.47%
• P/S Ratio: 1.80
• Revenue / Employee: $331.54K
• Employees: 9,100
• Market Cap: 4.33B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.88B	358.00M	14.22%
Dec 31, 2022	2.52B	-36.00M	-1.41%
Dec 31, 2021	2.55B	212.00M	9.06%
Dec 31, 2020	2.34B	134.00M	6.07%
Dec 31, 2019	2.21B	137.00M	6.62%